One hundred fifty-eight patients with 277 expanded skin cases during 2010 to 2014 were reviewed and photograph-evaluated for the expanded skin texture and regenerative condition. Overall texture of the expanded skin flaps (Good, Fair, Poor) were evaluated and documented by senior attending surgeons. The occurrence of five indications of skin regeneration limitation, including skin thickness, skin color, stretch mark, vessel varicose and skin lesion, during skin expansion were recorded. The correlation of indications to overall skin regeneration condition was statistically analyzed.
PURPOSE:
Bone tissue engineering remains hampered by inadequate scaffold design and regulatory limitations on autologous cell use. We developed a novel system to silence and reactivate TGF-ß activating kinase 1 (TAK1), which mediates TGF-β1 and BMP2. We hypothesize that Tak1 can be initially silenced to increase local cell proliferation followed by Tak1 reactivation to stimulate bone differentiation, providing scaffold and cell-free bone healing.
METHODS:
We developed a novel dual-recombinase system (Cre/lox; FLP/FRT) to allow silencing and reactivation of Tak1. Critical sized-calvarial defects were performed and mice received: 1. Ad.LacZ (control) 2. Ad.Cre (knockout) or 3. Ten days Ad.Cre (knockout) followed by Ad.FLP (reactivation) to modulate Tak1 expression. Cellular proliferation and differentiation were quantified histologically. MicroCT was used to quantify bone healing. In vitro studies with calvarial osteoblasts confirmed these findings.
RESULTS:
Loss of Tak1 with Ad.Cre increased cellular proliferation (Ki67 immunostaining; Fig. 1A ) while suppressing osteogenesis (Osterix immunostaining) within the defect. Ad.Cre followed by Ad.FLP stimulated increased cell proliferation followed by enhanced osteogenic differentiation. Timed Tak1 suppression followed by Tak1 activation improved bone healing compared to controls by microCT quantification. In vitro results (Fig. 1B, 1C ) with calvarial osteoblasts were consistent with in vivo findings.
CONCLUSION:
These results validate that TAK1 can be mediated therapeutically to first potentiate cellular proliferation and then stimulate osteogenic differentiation to maximize bone healing without introducing exogenous scaffolds or cells. PURPOSE: Previous studies have demonstrated the efficacy of 3D-printed bioactive ceramic (3DBC) scaffolds in the restoration of long bone defects. The objective of this study is to test the efficacy of the osteogenic agent dipyridamole on 3DBC scaffold-mediated healing of calvarial defects using a sheep model.
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DIPYRIDAMOLE-CONTAINING 3D-PRINTED BIOACTIVE CERAMIC SCAFFOLDS FOR THE TREATMENT OF CALVARIAL DEFECTS: AN EXPERIMENTAL STUDY IN SHEEP
METHODS:
Custom 3DBC scaffolds were either coated with collagen (control) or coated with collagen and immersed in 100 μM dipyridamole (DIPY). Sheep (n=5) were subjected to 4 trephine-induced (12 mm diameter) calvarial defects with immediate scaffold placement via two separate operations: anteriorly (control) and posteriorly (DIPY) on the right (3 weeks healing) and left (6 weeks healing) sides of the calvarium. Following sacrifice, defects were evaluated through microcomputed tomography and histologic analysis for bone, scaffold, and soft tissue quantification as a function of time in vivo. Statistical analysis was performed by a mixed model and significance was defined by p<0.05.
RESULTS:
Histologic evaluation demonstrated no signs of inflammation within the defects. Significantly higher percentage of bone formation (p=0.02) was observed for the DIPY-containing scaffolds. A significant increase in bone percentage was observed from 3 to 6 weeks in vivo irrespective of scaffold group (p<0.01). Differences between groups were more pronounced at 6 weeks in vivo (~90% more for DIPY). No exuberant or ectopic bone formation was observed in either experimental group.
CONCLUSION:
Defects treated with dipyridamolecontaining 3DBC scaffolds demonstrated significantly improved bone generation without histologic evidence of inflammation or ectopic bone formation. 
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